{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T20:38:55Z","timestamp":1789763935057,"version":"4.0.1"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:00:00Z","timestamp":1758672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:00:00Z","timestamp":1758672000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"US-Egypt Collaborative Research Grant Cycle 20, National Academy of Science (NAS), US-Science, Technology, and Innovation Funding Authority (STDF), Egypt","award":["45896"],"award-info":[{"award-number":["45896"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-18086-8","type":"journal-article","created":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T19:19:47Z","timestamp":1758741587000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Design and synthesis of novel small molecules targeting the Kv1.3 voltage-gated potassium ion channel"],"prefix":"10.1038","volume":"15","author":[{"given":"Ahmad","family":"Abdelwaly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.","family":"Helal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa","family":"M. Fathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamdy","family":"Alaaeldeen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael L.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled M.","family":"Darwish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,24]]},"reference":[{"issue":"5","key":"18086_CR1","doi-asserted-by":"publisher","first-page":"A259","DOI":"10.1016\/j.autrev.2009.12.002","volume":"9","author":"A Lleo","year":"2010","unstructured":"Lleo, A. et al. Definition of human autoimmunity\u2013autoantibodies versus autoimmune disease. Autoimmun. Rev. 9 (5), A259\u2013A266 (2010).","journal-title":"Autoimmun. Rev."},{"key":"18086_CR2","doi-asserted-by":"crossref","unstructured":"Ceccarelli, F., Agmon-Levin, N. & Perricone, C. Genetic Factors of Autoimmune Diseases 2017. J. Immunol. Res. 2017, 2789242. (2017).","DOI":"10.1155\/2017\/2789242"},{"issue":"3\u20134","key":"18086_CR3","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jaut.2009.09.001","volume":"33","author":"CL Burek","year":"2009","unstructured":"Burek, C. L. & Talor, M. V. Environmental triggers of autoimmune thyroiditis. J. Autoimmun. 33 (3\u20134), 183\u2013189 (2009).","journal-title":"J. Autoimmun."},{"issue":"3","key":"18086_CR4","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1002\/art.40371","volume":"70","author":"AH Sawalha","year":"2018","unstructured":"Sawalha, A. H. Editorial: the innate and adaptive immune response are both involved in Drug-Induced autoimmunity. Arthritis Rheumatol. 70 (3), 330\u2013333 (2018).","journal-title":"Arthritis Rheumatol."},{"issue":"4","key":"18086_CR5","first-page":"151","volume":"3","author":"L A","year":"2015","unstructured":"A, L. The world incidence and prevalence of autoimmune diseases is increasing. Int. J. Celiac Disease. 3 (4), 151\u2013155 (2015).","journal-title":"Int. J. Celiac Disease"},{"issue":"3","key":"18086_CR6","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S1568-9972(03)00006-5","volume":"2","author":"GS Cooper","year":"2003","unstructured":"Cooper, G. S. & Stroehla, B. C. The epidemiology of autoimmune diseases. Autoimmun. Rev. 2 (3), 119\u2013125 (2003).","journal-title":"Autoimmun. Rev."},{"issue":"7","key":"18086_CR7","first-page":"700","volume":"13","author":"S Sawcer","year":"2014","unstructured":"Sawcer, S., Franklin, R. J. & Ban, M. Multiple Scler. Genet. Lancet Neurol., 13(7): 700\u2013709. (2014).","journal-title":"Multiple Scler. Genet. Lancet Neurol."},{"issue":"8","key":"18086_CR8","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1111\/j.1464-5491.2006.01925.x","volume":"23","author":"DP Group","year":"2006","unstructured":"Group, D. P. Incidence and trends of childhood type 1 diabetes worldwide 1990\u20131999. Diabet. Med. 23 (8), 857\u2013866 (2006).","journal-title":"Diabet. Med."},{"issue":"3","key":"18086_CR9","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1055\/s-0034-1383730","volume":"34","author":"L Griffiths","year":"2014","unstructured":"Griffiths, L., Dyson, J. K. & Jones, D. E. The new epidemiology of primary biliary cirrhosis. Semin Liver Dis. 34 (3), 318\u2013328 (2014).","journal-title":"Semin Liver Dis."},{"issue":"3","key":"18086_CR10","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/apt.12373","volume":"38","author":"JY Kang","year":"2013","unstructured":"Kang, J. Y. et al. Systematic review: worldwide variation in the frequency of coeliac disease and changes over time. Aliment. Pharmacol. Ther. 38 (3), 226\u2013245 (2013).","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"9957","key":"18086_CR11","first-page":"1878","volume":"384","author":"L Lisnevskaia","year":"2014","unstructured":"Lisnevskaia, L., Murphy, G. & Isenberg, D. Systemic Lupus Erythematosus Lancet, 384(9957): 1878\u20131888. (2014).","journal-title":"Systemic Lupus Erythematosus Lancet"},{"issue":"23","key":"18086_CR12","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1056\/NEJMra1004965","volume":"365","author":"IB McInnes","year":"2011","unstructured":"McInnes, I. B. & Schett, G. The pathogenesis of rheumatoid arthritis. N Engl. J. Med. 365 (23), 2205\u20132219 (2011).","journal-title":"N Engl. J. Med."},{"issue":"10086","key":"18086_CR13","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1016\/S0140-6736(17)31472-1","volume":"389","author":"IB McInnes","year":"2017","unstructured":"McInnes, I. B. & Schett, G. Pathogenetic insights from the treatment of rheumatoid arthritis. Lancet 389 (10086), 2328\u20132337 (2017).","journal-title":"Lancet"},{"key":"18086_CR14","unstructured":"Committee, T. A. D. C. Progress in Autoimmune Disease Research. Report To Congress (The Autoimmune Diseases Coordinating Committee, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 2005)."},{"key":"18086_CR15","doi-asserted-by":"crossref","unstructured":"Hussain, Y. & Khan, H. Immunosuppressive Drugs, in Encyclopedia of Infection and Immunity. Copyright \u00a9 2022 Elsevier Inc. All rights reserved. pp. 726\u2009\u2013\u200940. (2022)","DOI":"10.1016\/B978-0-12-818731-9.00068-9"},{"key":"18086_CR16","doi-asserted-by":"publisher","first-page":"460","DOI":"10.3389\/fphar.2017.00460","volume":"8","author":"P Li","year":"2017","unstructured":"Li, P., Zheng, Y. & Chen, X. Drugs for autoimmune inflammatory diseases: from small molecule compounds to Anti-TNF biologics. Front. Pharmacol. 8, 460 (2017).","journal-title":"Front. Pharmacol."},{"issue":"11","key":"18086_CR17","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1007\/s40265-013-0089-0","volume":"73","author":"R Pazetti","year":"2013","unstructured":"Pazetti, R., P\u00eago-Fernandes, P. M. & Jatene, F. B. Adverse effects of immunosuppressant drugs upon airway epithelial cell and mucociliary clearance: implications for lung transplant recipients. Drugs 73 (11), 1157\u20131169 (2013).","journal-title":"Drugs"},{"key":"18086_CR18","doi-asserted-by":"publisher","first-page":"41","DOI":"10.4137\/JCNSD.S14049","volume":"6","author":"R Hoepner","year":"2014","unstructured":"Hoepner, R. et al. Efficacy and side effects of natalizumab therapy in patients with multiple sclerosis. J. Cent. Nerv. Syst. Dis. 6, 41\u201349 (2014).","journal-title":"J. Cent. Nerv. Syst. Dis."},{"issue":"9","key":"18086_CR19","first-page":"24","volume":"18","author":"ZA Marcum","year":"2010","unstructured":"Marcum, Z. A. & Hanlon, J. T. Recognizing the risks of chronic nonsteroidal Anti-Inflammatory drug use in older adults. Ann. Longterm Care. 18 (9), 24\u201327 (2010).","journal-title":"Ann. Longterm Care"},{"issue":"3","key":"18086_CR20","first-page":"199","volume":"52","author":"M DeBisschop","year":"2003","unstructured":"DeBisschop, M. What are the risks of long-term NSAIDs and COX-2 inhibitors? J. Fam Pract. 52 (3), 199\u2013200 (2003).","journal-title":"J. Fam Pract."},{"issue":"3","key":"18086_CR21","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1007\/s12325-012-0007-y","volume":"29","author":"MM Bonafede","year":"2012","unstructured":"Bonafede, M. M. et al. Cost per treated patient for etanercept, adalimumab, and Infliximab across adult indications: a claims analysis. Adv. Ther. 29 (3), 234\u2013248 (2012).","journal-title":"Adv. Ther."},{"key":"18086_CR22","doi-asserted-by":"publisher","first-page":"e148118","DOI":"10.1590\/1678-9199-jvatitd-1481-18","volume":"25","author":"IS Oliveira","year":"2019","unstructured":"Oliveira, I. S. et al. Scorpion toxins targeting Kv1.3 channels: insights into immunosuppression. J. Venom. Anim. Toxins Incl. Trop. Dis. 25, e148118 (2019).","journal-title":"J. Venom. Anim. Toxins Incl. Trop. Dis."},{"issue":"10","key":"18086_CR23","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1038\/s41401-024-01275-y","volume":"45","author":"Y Zhou","year":"2024","unstructured":"Zhou, Y. et al. Effects of Kv1.3 knockout on pyramidal neuron excitability and synaptic plasticity in piriform cortex of mice. Acta Pharmacol. Sin. 45 (10), 2045\u20132060 (2024).","journal-title":"Acta Pharmacol. Sin."},{"issue":"9","key":"18086_CR24","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1002\/glia.23457","volume":"66","author":"J Di Lucente","year":"2018","unstructured":"Di Lucente, J. et al. The voltage-gated potassium channel Kv1.3 is required for microglial pro-inflammatory activation in vivo. Glia 66 (9), 1881\u20131895 (2018).","journal-title":"Glia"},{"issue":"3","key":"18086_CR25","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s00232-025-00341-8","volume":"258","author":"R Bhoi","year":"2025","unstructured":"Bhoi, R. et al. Role of ion channels in alzheimer\u2019s disease pathophysiology. J. Membr. Biol. 258 (3), 187\u2013212 (2025).","journal-title":"J. Membr. Biol."},{"key":"18086_CR26","doi-asserted-by":"crossref","unstructured":"Zhang, X. et al. Blockade of Kv1.3 potassium channel inhibits Microglia-Mediated neuroinflammation in epilepsy. Int. J. Mol. Sci., 23 (23), 14693 (2022).","DOI":"10.3390\/ijms232314693"},{"key":"18086_CR27","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/978-3-642-14426-4_12","volume":"52","author":"K Tucker","year":"2010","unstructured":"Tucker, K. et al. The olfactory bulb: A metabolic sensor of brain insulin and glucose concentrations via a Voltage-Gated potassium channel. Results Probl. Cell. Differ. 52, 147\u2013157 (2010).","journal-title":"Results Probl. Cell. Differ."},{"issue":"3","key":"18086_CR28","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/S0896-6273(03)00844-4","volume":"41","author":"DA Fadool","year":"2004","unstructured":"Fadool, D. A. et al. Kv1.3 channel gene-targeted deletion produces Super-Smeller mice with altered glomeruli, interacting scaffolding proteins, and biophysics. Neuron 41 (3), 389\u2013404 (2004).","journal-title":"Neuron"},{"key":"18086_CR29","doi-asserted-by":"crossref","unstructured":"Kazama, I., T. Tamada, and M. Tachi, Usefulness of targeting lymphocyte Kv1.3-channels in the treatment of respiratory diseases. Inflamm. Res. 64, 753-65 (2015).","DOI":"10.1007\/s00011-015-0855-4"},{"issue":"1","key":"18086_CR30","doi-asserted-by":"publisher","first-page":"436572","DOI":"10.1155\/2015\/436572","volume":"2015","author":"I Kazama","year":"2015","unstructured":"Kazama, I. Roles of lymphocyte Kv1.3-Channels in the pathogenesis of renal diseases and novel therapeutic implications of targeting the channels. Mediat. Inflamm. 2015 (1), 436572 (2015).","journal-title":"Mediat. Inflamm."},{"issue":"6","key":"18086_CR31","doi-asserted-by":"publisher","first-page":"F1258","DOI":"10.1152\/ajprenal.00374.2010","volume":"299","author":"T Hyodo","year":"2010","unstructured":"Hyodo, T. et al. Voltage-gated potassium channel Kv1.3 blocker as a potential treatment for rat anti-glomerular basement membrane glomerulonephritis. Am. J. Physiol. Ren. Physiol. 299 (6), F1258\u2013F1269 (2010).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"11","key":"18086_CR32","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1172\/JCI16921","volume":"111","author":"H Wulff","year":"2003","unstructured":"Wulff, H. et al. The voltage-gated Kv1.3 K(+) channel in effector memory T cells as new target for MS. J. Clin. Invest. 111 (11), 1703\u20131713 (2003).","journal-title":"J. Clin. Invest."},{"issue":"5","key":"18086_CR33","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.1073\/pnas.0438057100","volume":"100","author":"G Panyi","year":"2003","unstructured":"Panyi, G. et al. Colocalization and nonrandom distribution of Kv1.3 potassium channels and CD3 molecules in the plasma membrane of human T lymphocytes. Proc. Natl. Acad. Sci. U S A. 100 (5), 2592\u20132597 (2003).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"5","key":"18086_CR34","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1073\/pnas.0307421100","volume":"101","author":"G Panyi","year":"2004","unstructured":"Panyi, G. et al. Kv1.3 potassium channels are localized in the immunological synapse formed between cytotoxic and target cells. Proc. Natl. Acad. Sci. U S A. 101 (5), 1285\u20131290 (2004).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"46","key":"18086_CR35","doi-asserted-by":"publisher","first-page":"17414","DOI":"10.1073\/pnas.0605136103","volume":"103","author":"C Beeton","year":"2006","unstructured":"Beeton, C. et al. Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases. Proc. Natl. Acad. Sci. U S A. 103 (46), 17414\u201317419 (2006).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"4","key":"18086_CR36","doi-asserted-by":"publisher","first-page":"C1431","DOI":"10.1152\/ajpcell.00376.2006","volume":"292","author":"SA Nicolaou","year":"2007","unstructured":"Nicolaou, S. A. et al. The Ca(2+)-activated K(+) channel KCa3.1 compartmentalizes in the immunological synapse of human T lymphocytes. Am. J. Physiol. Cell. Physiol. 292 (4), C1431\u2013C1439 (2007).","journal-title":"Am. J. Physiol. Cell. Physiol."},{"issue":"10","key":"18086_CR37","doi-asserted-by":"publisher","first-page":"6296","DOI":"10.4049\/jimmunol.0900613","volume":"183","author":"SA Nicolaou","year":"2009","unstructured":"Nicolaou, S. A. et al. Localization of Kv1.3 channels in the immunological synapse modulates the calcium response to antigen stimulation in T lymphocytes. J. Immunol. 183 (10), 6296\u20136302 (2009).","journal-title":"J. Immunol."},{"issue":"47","key":"18086_CR38","doi-asserted-by":"publisher","first-page":"37137","DOI":"10.1074\/jbc.M003941200","volume":"275","author":"S Ghanshani","year":"2000","unstructured":"Ghanshani, S. et al. Up-regulation of the IKCa1 potassium channel during T-cell activation. Molecular mechanism and functional consequences. J. Biol. Chem. 275 (47), 37137\u201337149 (2000).","journal-title":"J. Biol. Chem."},{"issue":"24","key":"18086_CR39","doi-asserted-by":"publisher","first-page":"13942","DOI":"10.1073\/pnas.241497298","volume":"98","author":"C Beeton","year":"2001","unstructured":"Beeton, C. et al. Selective Blockade of T lymphocyte K(+) channels ameliorates experimental autoimmune encephalomyelitis, a model for multiple sclerosis. Proc. Natl. Acad. Sci. U S A. 98 (24), 13942\u201313947 (2001).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"4","key":"18086_CR40","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1124\/pr.57.4.10","volume":"57","author":"GA Gutman","year":"2005","unstructured":"Gutman, G. A. et al. International union of pharmacology. LIII. Nomenclature and molecular relationships of voltage-gated potassium channels. Pharmacol. Rev. 57 (4), 473\u2013508 (2005).","journal-title":"Pharmacol. Rev."},{"key":"18086_CR41","doi-asserted-by":"crossref","unstructured":"Liu, S. et al. Structures of wild-type and H451N mutant human lymphocyte potassium channel K(V)1.3, Cell Discov. 7 (1), (2021).","DOI":"10.1038\/s41421-021-00269-y"},{"issue":"1","key":"18086_CR42","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/j.1600-065X.2009.00816.x","volume":"231","author":"MD Cahalan","year":"2009","unstructured":"Cahalan, M. D. & Chandy, K. G. The functional network of ion channels in T lymphocytes. Immunol. Rev. 231 (1), 59\u201387 (2009).","journal-title":"Immunol. Rev."},{"issue":"3","key":"18086_CR43","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1124\/jpet.112.191890","volume":"342","author":"EJ Tarcha","year":"2012","unstructured":"Tarcha, E. J. et al. Durable Pharmacological responses from the peptide ShK-186, a specific Kv1.3 channel inhibitor that suppresses T cell mediators of autoimmune disease. J. Pharmacol. Exp. Ther. 342 (3), 642\u2013653 (2012).","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"11","key":"18086_CR44","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/nrd2445","volume":"6","author":"PD Leeson","year":"2007","unstructured":"Leeson, P. D. & Springthorpe, B. The influence of drug-like concepts on decision-making in medicinal chemistry. Nat. Rev. Drug Discov. 6 (11), 881\u2013890 (2007).","journal-title":"Nat. Rev. Drug Discov"},{"key":"18086_CR45","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.cbpa.2017.02.015","volume":"38","author":"KG Chandy","year":"2017","unstructured":"Chandy, K. G. & Norton, R. S. Peptide blockers of K. Curr. Opin. Chem. Biol. 38, 97\u2013107 (2017).","journal-title":"Curr. Opin. Chem. Biol."},{"key":"18086_CR46","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1472-6807-7-5","volume":"7","author":"I Bruhova","year":"2007","unstructured":"Bruhova, I. & Zhorov, B. S. Monte Carlo-energy minimization of correolide in the Kv1.3 channel: possible role of potassium ion in ligand-receptor interactions. BMC Struct. Biol. 7, 5 (2007).","journal-title":"BMC Struct. Biol."},{"issue":"16","key":"18086_CR47","doi-asserted-by":"publisher","first-page":"4922","DOI":"10.1021\/bi982954w","volume":"38","author":"JP Felix","year":"1999","unstructured":"Felix, J. P. et al. Identification and biochemical characterization of a novel nortriterpene inhibitor of the human lymphocyte voltage-gated potassium channel, Kv1.3. Biochemistry 38 (16), 4922\u20134930 (1999).","journal-title":"Biochemistry"},{"issue":"5","key":"18086_CR48","doi-asserted-by":"publisher","first-page":"C1837","DOI":"10.1152\/ajpcell.00405.2006","volume":"292","author":"CV Remillard","year":"2007","unstructured":"Remillard, C. V. et al. Function of Kv1.5 channels and genetic variations of KCNA5 in patients with idiopathic pulmonary arterial hypertension. Am. J. Physiol. Cell. Physiol. 292 (5), C1837\u2013C1853 (2007).","journal-title":"Am. J. Physiol. Cell. Physiol."},{"issue":"4","key":"18086_CR49","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1021\/jm050839v","volume":"49","author":"AJ Harvey","year":"2006","unstructured":"Harvey, A. J. et al. A new class of blockers of the voltage-gated potassium channel Kv1.3 via modification of the 4- or 7-position of khellinone. J. Med. Chem. 49 (4), 1433\u20131441 (2006).","journal-title":"J. Med. Chem."},{"issue":"9","key":"18086_CR50","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1021\/jm030523s","volume":"47","author":"JB Baell","year":"2004","unstructured":"Baell, J. B. et al. Khellinone derivatives as blockers of the voltage-gated potassium channel Kv1.3: synthesis and immunosuppressive activity. J. Med. Chem. 47 (9), 2326\u20132336 (2004).","journal-title":"J. Med. Chem."},{"issue":"5","key":"18086_CR51","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1124\/mol.105.015669","volume":"68","author":"A Schmitz","year":"2005","unstructured":"Schmitz, A. et al. Design of PAP-1, a selective small molecule Kv1.3 blocker, for the suppression of effector memory T cells in autoimmune diseases. Mol. Pharmacol. 68 (5), 1254\u20131270 (2005).","journal-title":"Mol. Pharmacol."},{"issue":"6","key":"18086_CR52","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/S0960-894X(03)00014-3","volume":"13","author":"S Miao","year":"2003","unstructured":"Miao, S. et al. Benzamide derivatives as blockers of Kv1.3 ion channel. Bioorg. Med. Chem. Lett. 13 (6), 1161\u20131164 (2003).","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"21","key":"18086_CR53","doi-asserted-by":"publisher","first-page":"5161","DOI":"10.1111\/bph.13283","volume":"172","author":"M Faouzi","year":"2015","unstructured":"Faouzi, M., Starkus, J. & Penner, R. State-dependent blocking mechanism of Kv 1.3 channels by the antimycobacterial drug Clofazimine. Br. J. Pharmacol. 172 (21), 5161\u20135173 (2015).","journal-title":"Br. J. Pharmacol."},{"issue":"8","key":"18086_CR54","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1021\/jm001007u","volume":"44","author":"I Butensch\u00f6n","year":"2001","unstructured":"Butensch\u00f6n, I., M\u00f6ller, K. & H\u00e4nsel, W. Angular Methoxy-Substituted Furo- and pyranoquinolinones as blockers of the Voltage-Gated potassium channel Kv1.3. J. Med. Chem. 44 (8), 1249\u20131256 (2001).","journal-title":"J. Med. Chem."},{"issue":"34","key":"18086_CR55","doi-asserted-by":"publisher","first-page":"11137","DOI":"10.1021\/bi990336p","volume":"38","author":"SG Wanner","year":"1999","unstructured":"Wanner, S. G. et al. WIN 17317-3, a new High-Affinity probe for Voltage-Gated sodium channels. Biochemistry 38 (34), 11137\u201311146 (1999).","journal-title":"Biochemistry"},{"issue":"1","key":"18086_CR56","doi-asserted-by":"publisher","first-page":"6991","DOI":"10.1038\/s41598-021-86460-3","volume":"11","author":"K Soliman","year":"2021","unstructured":"Soliman, K. et al. Predicting the membrane permeability of organic fluorescent probes by the deep neural network based lipophilicity descriptor DeepFl-LogP. Sci. Rep. 11 (1), 6991 (2021).","journal-title":"Sci. Rep."},{"issue":"1","key":"18086_CR57","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2174\/092986709787002817","volume":"16","author":"S Prasanna","year":"2009","unstructured":"Prasanna, S. & Doerksen, R. J. Topological Polar surface area: a useful descriptor in 2D-QSAR. Curr. Med. Chem. 16 (1), 21\u201341 (2009).","journal-title":"Curr. Med. Chem."},{"issue":"4","key":"18086_CR58","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1021\/jm801389m","volume":"52","author":"J Fernandes","year":"2009","unstructured":"Fernandes, J. & Gattass, C. R. Topological Polar surface area defines substrate transport by multidrug resistance associated protein 1 (MRP1\/ABCC1). J. Med. Chem. 52 (4), 1214\u20131218 (2009).","journal-title":"J. Med. Chem."},{"issue":"3","key":"18086_CR59","doi-asserted-by":"publisher","first-page":"663","DOI":"10.3390\/molecules26030663","volume":"26","author":"T Szab\u00f3","year":"2021","unstructured":"Szab\u00f3, T., Volk, B. & Milen, M. Recent advances in the synthesis of \u03b2-carboline alkaloids. Molecules 26 (3), 663 (2021).","journal-title":"Molecules"},{"issue":"5","key":"18086_CR60","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/s10295-019-02151-z","volume":"46","author":"S Ueda","year":"2019","unstructured":"Ueda, S. et al. Identification of biosynthetic genes for the \u03b2-carboline alkaloid Kitasetaline and production of the fluorinated derivatives by heterologous expression. J. Ind. Microbiol. Biotechnol. 46 (5), 739\u2013750 (2019).","journal-title":"J. Ind. Microbiol. Biotechnol."},{"key":"18086_CR61","doi-asserted-by":"crossref","unstructured":"Bueno, M. L. P. et al. \u03b2-Carboline derivatives are potent against acute myeloid leukemia in vitro and in vivo. Pharmacol. Rep. 76 (4), 838\u2013850 (2024).","DOI":"10.1007\/s43440-024-00614-4"},{"key":"18086_CR62","doi-asserted-by":"crossref","unstructured":"Dalpozzo, R. The chiral pool in the Pictet-Spengler reaction for the synthesis of \u03b2-Carbolines. Molecules, 21 (6), 699 (2016).","DOI":"10.3390\/molecules21060699"},{"issue":"11","key":"18086_CR63","doi-asserted-by":"publisher","first-page":"3863","DOI":"10.1021\/jo100397a","volume":"75","author":"HM Guo","year":"2010","unstructured":"Guo, H. M. et al. Synthesis of acyclic nucleosides with a chiral amino side chain by the Mitsunobu coupling reaction. J. Org. Chem. 75 (11), 3863\u20133866 (2010).","journal-title":"J. Org. Chem."},{"issue":"4","key":"18086_CR64","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1021\/acscombsci.6b00184","volume":"19","author":"RN Rao","year":"2017","unstructured":"Rao, R. N., Maiti, B. & Chanda, K. Application of Pictet-Spengler reaction to Indole-Based alkaloids containing Tetrahydro-\u03b2-carboline scaffold in combinatorial chemistry. ACS Comb. Sci. 19 (4), 199\u2013228 (2017).","journal-title":"ACS Comb. Sci."},{"key":"18086_CR65","doi-asserted-by":"crossref","unstructured":"Teisseyre, A., \u015aroda-Pomianek, K. & Palko-Labuz, A. The Patch-Clamp Technique and its application in studies on Voltage-Gated potassium channels Kv1. 3 in normal and cancer cells. IntechOpen . On-line chapter at https:\/\/www.intechopen.com\/chapters\/1190637 (2024).","DOI":"10.5772\/intechopen.1006991"},{"key":"18086_CR66","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.toxicon.2014.05.002","volume":"87","author":"A Bartok","year":"2014","unstructured":"Bartok, A. et al. Margatoxin is a non-selective inhibitor of human Kv1. 3 K\u2009+\u2009channels. Toxicon 87, 6\u201316 (2014).","journal-title":"Toxicon"},{"issue":"5","key":"18086_CR67","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1085\/jgp.110.5.601","volume":"110","author":"MR Bowlby","year":"1997","unstructured":"Bowlby, M. R. et al. Modulation of the Kv1.3 potassium channel by receptor tyrosine kinases. J. Gen. Physiol. 110 (5), 601\u2013610 (1997).","journal-title":"J. Gen. Physiol."},{"issue":"1","key":"18086_CR68","doi-asserted-by":"publisher","first-page":"3854","DOI":"10.1038\/s41467-022-31285-5","volume":"13","author":"P Selvakumar","year":"2022","unstructured":"Selvakumar, P. et al. Structures of the T cell potassium channel Kv1.3 with Immunoglobulin modulators. Nat. Commun. 13 (1), 3854 (2022).","journal-title":"Nat. Commun."},{"issue":"7","key":"18086_CR69","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1084\/jem.191.7.1167","volume":"191","author":"M Levite","year":"2000","unstructured":"Levite, M. et al. Extracellular K(+) and opening of voltage-gated potassium channels activate T cell integrin function: physical and functional association between Kv1.3 channels and beta1 integrins. J. Exp. Med. 191 (7), 1167\u20131176 (2000).","journal-title":"J. Exp. Med."},{"issue":"1","key":"18086_CR70","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3892\/etm.2017.4490","volume":"14","author":"J Zhu","year":"2017","unstructured":"Zhu, J. et al. T-lymphocyte K(v)1.3 channel activation triggers the NLRP3 inflammasome signaling pathway in hypertensive patients. Exp. Ther. Med. 14 (1), 147\u2013154 (2017).","journal-title":"Exp. Ther. Med."},{"issue":"8","key":"18086_CR71","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1038\/sj.bjp.0702480","volume":"126","author":"DC Hanson","year":"1999","unstructured":"Hanson, D. C. et al. UK-78,282, a novel piperidine compound that potently blocks the Kv1.3 voltage-gated potassium channel and inhibits human T cell activation. Br. J. Pharmacol. 126 (8), 1707\u20131716 (1999).","journal-title":"Br. J. Pharmacol."},{"issue":"8","key":"18086_CR72","doi-asserted-by":"publisher","first-page":"885","DOI":"10.4155\/fmc.14.50","volume":"6","author":"Z Fang","year":"2014","unstructured":"Fang, Z. et al. Conformational restriction: an effective tactic in \u2018follow-on\u2019-based drug discovery. Future Med. Chem. 6 (8), 885\u2013901 (2014).","journal-title":"Future Med. Chem."},{"issue":"34","key":"18086_CR73","doi-asserted-by":"publisher","first-page":"12877","DOI":"10.1021\/ja4064469","volume":"135","author":"MA D\u00fcfert","year":"2013","unstructured":"D\u00fcfert, M. A., Billingsley, K. L. & Buchwald, S. L. Suzuki-Miyaura cross-coupling of unprotected, nitrogen-rich heterocycles: substrate scope and mechanistic investigation. J. Am. Chem. Soc. 135 (34), 12877\u201312885 (2013).","journal-title":"J. Am. Chem. Soc."},{"key":"18086_CR74","doi-asserted-by":"publisher","first-page":"104510","DOI":"10.1016\/j.bioorg.2020.104510","volume":"106","author":"AM Mohassab","year":"2021","unstructured":"Mohassab, A. M. et al. Design and synthesis of novel quinoline\/chalcone\/1,2,4-triazole hybrids as potent antiproliferative agent targeting EGFR and BRAF(V600E) kinases. Bioorg. Chem. 106, 104510 (2021).","journal-title":"Bioorg. Chem."},{"issue":"W1","key":"18086_CR75","doi-asserted-by":"publisher","first-page":"W513","DOI":"10.1093\/nar\/gkae303","volume":"52","author":"P Banerjee","year":"2024","unstructured":"Banerjee, P. et al. ProTox 3.0: a webserver for the prediction of toxicity of chemicals. Nucleic Acids Res. 52 (W1), W513\u2013w520 (2024).","journal-title":"Nucleic Acids Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18086-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18086-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18086-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T21:04:49Z","timestamp":1758747889000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18086-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,24]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["18086"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-18086-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,24]]},"assertion":[{"value":"21 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"32756"}}